Iratumumab
Encyclopedia
Iratumumab is a human
monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30
-positive lymphoma including Hodgkin's disease.
This drug was developed by Medarex
, Inc.
Human
Humans are the only living species in the Homo genus...
monoclonal antibody used in the treatment of oncological diseases such as relapsed refractory CD30
CD30
CD30, also known as TNFRSF8, is a cell membrane protein of the tumor necrosis factor receptor family and tumor marker.This receptor is expressed by activated, but not by resting, T and B cells. TRAF2 and TRAF5 can interact with this receptor, and mediate the signal transduction that leads to the...
-positive lymphoma including Hodgkin's disease.
This drug was developed by Medarex
Medarex
Medarex is an American biotechnology company owned by Bristol Myers Squibb and based in Princeton, New Jersey. The company has manufacturing facilities in Bloomsbury and Annandale, New Jersey, and research facilities in Milpitas and Sunnyvale, California. Medarex specializes in therapeutic...
, Inc.